经导管心臟瓣膜置换术市场规模、份额和成长分析（按产品、手术方法、最终用途、应用和地区划分）－2026-2033年产业预测

预计到 2024 年，经导管心臟瓣膜置换市场规模将达到 75 亿美元，到 2025 年将达到 86 亿美元，到 2033 年将达到 257.8 亿美元，在预测期（2026-2033 年）内，复合年增长率为 14.7%。

经导管心臟瓣膜置换术市场经历了显着成长，它已成为传统开胸手术的替代方案，尤其适用于重度主动脉瓣疾病患者。经导管主动脉瓣置换术术（TAVR）等手术透过导管植入人工瓣膜，具有许多优势，包括降低手术风险、缩短住院时间和加快復健速度。这种方法对高风险患者和以往被认为不适合手术的患者尤其有利。市场成长的主要驱动因素包括技术创新、患者群体不断扩大以及医疗专业人员对该技术的接受度不断提高。人口老化和心血管疾病发生率的上升进一步推动了对TAVR的需求。製造商持续加大研发投入，旨在改善瓣膜设计和手术流程，最终改善心血管疾病患者的治疗效果和生活品质。

推动经导管心臟瓣膜置换市场发展的因素

瓣膜性心臟病，尤其是主动脉瓣狭窄的盛行率不断上升，受到全球人口老化的显着影响，导致经导管心臟瓣膜置换术（THVR）的需求增加。随着老龄化，人们罹患瓣膜相关疾病的风险也随之增加，因此寻求THVR治疗的患者人数也随之增加。这种人口结构的变化不仅增加了瓣膜性心臟病的发生率，也凸显了对高效、微创治疗方法（如THVR）的需求，从而重塑了这些先进心臟手术的市场格局。因此，THVR的需求正在上升，反映了这些社会趋势。

经导管心臟瓣膜置换市场的阻碍因素

经导管心臟瓣膜置换术市场面临诸多限制因素，主要源自于此类手术的高前期成本。器械及所需专用设备的费用可能相当可观，这阻碍了医疗机构采用这些技术。此外，健保报销政策的不一致和地区监管差异也会造成财务上的复杂性，最终限制患者获得这些先进疗法的机会。这些因素共同构成了阻碍经导管心臟瓣膜置换术解决方案在医疗市场发展和广泛应用的挑战。

经导管心臟瓣膜置换市场市场趋势

经导管心臟瓣膜置换术（THVR）市场正经历着动态的变革，其特点是科技的快速发展正在改变患者照护。先进的瓣膜设计、尖端的成像技术以及改进的输送机制的出现，使得手术更加有效且创伤更小。这些创新不仅最大限度地降低了风险和併发症，还扩大了适用患者群体。因此，THVR 越来越受到青睐，逐渐取代了传统的外科手术，并迅速重塑了主动脉瓣疾病的治疗模式。这推动了市场扩张，并促进了全球医疗机构对该技术的广泛应用。

目录

介绍

• 调查目标
• 调查范围
• 定义

调查方法

• 资讯收集
• 二手资料和一手资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 细分市场机会分析

市场动态与展望

• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制与挑战
• 波特分析

关键市场考察

• 关键成功因素
• 竞争程度
• 关键投资机会
• 市场生态系统
• 市场吸引力指数（2025）
• PESTEL 分析
• 总体经济指标
• 价值链分析
• 定价分析

全球经导管心臟瓣膜置换术市场规模（按产品和复合年增长率划分）（2026-2033 年）

• 经导管肺动脉瓣置换术
• 经导管二尖瓣瓣膜修復与置换术
• 经导管主动脉瓣置换术

全球经导管心臟瓣膜置换术市场规模（按手术方式和复合年增长率划分）（2026-2033 年）

• 经心尖入路
• 经股骨入路
• 其他的

全球经导管心臟瓣膜置换术市场规模（按最终用途和复合年增长率划分）（2026-2033 年）

• 导管检查室
• 医院

全球经导管心臟瓣膜置换术市场规模（按应用及复合年增长率划分）（2026-2033 年）

• 肺动脉瓣膜疾病
• 二尖瓣疾病
• 主动脉瓣疾病

全球经导管心臟瓣膜置换术市场规模及复合年增长率（2026-2033）

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 亚太其他地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地区
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前五大公司对比
• 主要企业的市场定位（2025 年）
• 主要市场参与者所采取的策略
• 近期市场趋势
• 公司市占率分析（2025 年）
• 主要企业公司简介
  • 公司详情
  • 产品系列分析
  • 依业务板块进行公司股票分析
  • 2021-2023年营收年比比较

主要企业简介

• Edwards Lifesciences Corporation（USA）
• Medtronic plc（Ireland）
• Boston Scientific Corporation（USA）
• Abbott Laboratories（USA）
• JenaValve Technology, Inc.（USA）
• SYMETIS（Switzerland）
• Braile Biomedica（Brazil）
• CryoLife, Inc.（USA）
• Micro Interventional Devices, Inc.（USA）
• LivaNova PLC（UK）
• Meril Life Sciences Pvt. Ltd.（India）
• Venus Medtech（Hangzhou）Inc.（China）
• Suzhou Jiecheng Medical Technology Co. Ltd.（China）
• Peijia Medical Limited（China）
• Blue Sail Medical Co., Ltd.（China）
• Colibri Heart Valve LLC（USA）
• HighLife SAS（France）
• Neovasc Inc.（Canada）
• St. Jude Medical, Inc.（USA）

结论与建议

Transcatheter Heart Valve Replacement Market size was valued at USD 7.5 Billion in 2024 and is poised to grow from USD 8.6 Billion in 2025 to USD 25.78 Billion by 2033, growing at a CAGR of 14.7% during the forecast period (2026-2033).

The transcatheter heart valve replacement market is experiencing significant growth as it emerges as a preferred alternative to traditional open-heart surgery, particularly for patients with severe aortic valve disease. With procedures like TAVR, which involves implanting a prosthetic valve through catheterization, significant benefits include reduced surgical risks, shorter hospital stays, and faster recovery times. This approach is especially valuable for high-risk or previously inoperable patients. Key drivers of market expansion include technological innovations, a widening patient demographic, and increased acceptance among healthcare practitioners. The aging population and heightened incidence of cardiovascular conditions further amplify demand for TAVR. Continuous investment in research and development from manufacturers aims to enhance valve designs and procedural techniques, ultimately promising improved patient outcomes and quality of life in cardiovascular care.

Top-down and bottom-up approaches were used to estimate and validate the size of the Transcatheter Heart Valve Replacement market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Transcatheter Heart Valve Replacement Market Segments Analysis

Global Transcatheter Heart Valve Replacement Market is segmented by product, surgical approach, end-use, application and region. Based on product, the market is segmented into transcatheter pulmonary valve replacement, transcatheter mitral valve repair & replacement and transcatheter aortic valve replacement. Based on surgical approach, the market is segmented into transapical approach, transfemoral approach and others. Based on end-use, the market is segmented into cath labs and hospitals. Based on application, the market is segmented into pulmonary valvular heart disease, mitral valvular heart disease and aortic valvular heart disease. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Transcatheter Heart Valve Replacement Market

The growing prevalence of heart valve diseases, particularly aortic stenosis, is significantly influenced by the aging population worldwide, leading to heightened demand for transcatheter heart valve replacement (THVR). As individuals age, they are more susceptible to developing valve-related conditions, which in turn expands the number of patients seeking THVR interventions. This demographic shift toward an older population not only increases the incidence of heart valve issues but also emphasizes the need for effective, minimally invasive solutions such as THVR, ultimately shaping the market landscape for these advanced cardiac treatments. The demand for THVR is thus on the rise, reflecting these societal trends.

Restraints in the Transcatheter Heart Valve Replacement Market

The Transcatheter Heart Valve Replacement market faces several constraints, primarily due to the high initial costs involved in these procedures. The expenses related to the devices and the necessary specialized equipment can be significant, which may deter healthcare providers from adopting these technologies. Furthermore, inconsistencies in reimbursement policies and varying regulations across different regions can complicate the financial aspects, ultimately limiting patient access to these advanced treatments. These factors collectively pose challenges that may impede the growth and wider acceptance of transcatheter heart valve replacement solutions in the healthcare market.

Market Trends of the Transcatheter Heart Valve Replacement Market

The Transcatheter Heart Valve Replacement (THVR) market is experiencing a dynamic evolution characterized by rapid technological advancements that are transforming patient care. The emergence of sophisticated valve designs, cutting-edge imaging modalities, and enhanced delivery mechanisms is facilitating more effective and less invasive procedures. These innovations are not only minimizing risks and complications but also broadening the demographic of patients eligible for treatment. Consequently, the growing preference for THVR over traditional surgical options is rapidly reshaping treatment paradigms for aortic valve diseases, propelling market expansion and fostering increased adoption among healthcare providers globally.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global Transcatheter Heart Valve Replacement Market Size by Product & CAGR (2026-2033)

• Market Overview
• Transcatheter Pulmonary Valve Replacement
• Transcatheter Mitral Valve Repair & Replacement
• Transcatheter Aortic Valve Replacement

Global Transcatheter Heart Valve Replacement Market Size by Surgical Approach & CAGR (2026-2033)

• Market Overview
• Transapical Approach
• Transfemoral Approach
• Others

Global Transcatheter Heart Valve Replacement Market Size by End-Use & CAGR (2026-2033)

• Market Overview
• Cath Labs
• Hospitals

Global Transcatheter Heart Valve Replacement Market Size by Application & CAGR (2026-2033)

• Market Overview
• Pulmonary Valvular Heart Disease
• Mitral Valvular Heart Disease
• Aortic Valvular Heart Disease

Global Transcatheter Heart Valve Replacement Market Size & CAGR (2026-2033)

• North America (Product, Surgical Approach, End-Use, Application)
  • US
  • Canada
• Europe (Product, Surgical Approach, End-Use, Application)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product, Surgical Approach, End-Use, Application)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product, Surgical Approach, End-Use, Application)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product, Surgical Approach, End-Use, Application)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

• Edwards Lifesciences Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medtronic plc (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boston Scientific Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• JenaValve Technology, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SYMETIS (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Braile Biomedica (Brazil)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CryoLife, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Micro Interventional Devices, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• LivaNova PLC (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Meril Life Sciences Pvt. Ltd. (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Venus Medtech (Hangzhou) Inc. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Suzhou Jiecheng Medical Technology Co. Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Peijia Medical Limited (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Blue Sail Medical Co., Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Colibri Heart Valve LLC (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• HighLife SAS (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Neovasc Inc. (Canada)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• St. Jude Medical, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations